(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol

C25H33N11O4 — CID 70099154

IUPAC(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol
SMILESCCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NC5CCNC5)nc43)[C@H](O)[C@@H]2O)n1
InChIInChI=1S/C25H33N11O4/c1-2-36-33-22(32-34-36)20-18(38)19(39)24(40-20)35-13-27-17-21(28-16(12-37)10-14-6-4-3-5-7-14)30-25(31-23(17)35)29-15-8-9-26-11-15/h3-7,13,15-16,18-20,24,26,37-39H,2,8-12H2,1H3,(H2,28,29,30,31)/t15?,16-,18-,19+,20-,24+/m0/s1
InChIKeyBMGUGWJAVBJODA-NUNSXDRSSA-N
MW551.61 g/mol
LogP-0.39
Rot. Bonds10

About (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol

(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol (PubChem CID 70099154) has the molecular formula C25H33N11O4 and a molecular weight of 551.61 g/mol. Its IUPAC name is (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol.

Molecular Properties

Compound Name(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol
PubChem CID70099154
Molecular FormulaC25H33N11O4
Molecular Weight551.61 g/mol
Exact Mass551.27
IUPAC Name(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol
SMILESCCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NC5CCNC5)nc43)[C@H](O)[C@@H]2O)n1
InChIInChI=1S/C25H33N11O4/c1-2-36-33-22(32-34-36)20-18(38)19(39)24(40-20)35-13-27-17-21(28-16(12-37)10-14-6-4-3-5-7-14)30-25(31-23(17)35)29-15-8-9-26-11-15/h3-7,13,15-16,18-20,24,26,37-39H,2,8-12H2,1H3,(H2,28,29,30,31)/t15?,16-,18-,19+,20-,24+/m0/s1
InChIKeyBMGUGWJAVBJODA-NUNSXDRSSA-N
XLogP-0.39
TPSA193.21 Ų
H-Bond Donors6
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500551.61
LogP ≤ 5-0.39
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1015

Analyze (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol?
The IUPAC name of (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol (CID 70099154) is (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol.
What is the SMILES notation for (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol?
The canonical SMILES for (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol is CCn1nnc([C@H]2O[C@@H](n3cnc4c(N[C@H](CO)Cc5ccccc5)nc(NC5CCNC5)nc43)[C@H](O)[C@@H]2O)n1.
What is the InChIKey of (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol?
The InChIKey is BMGUGWJAVBJODA-NUNSXDRSSA-N. The full InChI is InChI=1S/C25H33N11O4/c1-2-36-33-22(32-34-36)20-18(38)19(39)24(40-20)35-13-27-17-21(28-16(12-37)10-14-6-4-3-5-7-14)30-25(31-23(17)35)29-15-8-9-26-11-15/h3-7,13,15-16,18-20,24,26,37-39H,2,8-12H2,1H3,(H2,28,29,30,31)/t15?,16-,18-,19+,20-,24+/m0/s1.
What are the key properties of (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol?
(2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol has a molecular weight of 551.61 g/mol, XLogP of -0.39, 10 rotatable bonds, 6 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4R,5R)-2-(2-ethyltetrazol-5-yl)-5-[6-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-2-(pyrrolidin-3-ylamino)purin-9-yl]oxolane-3,4-diol is sourced from PubChem (CID 70099154), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).